This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Walter I. Hofman, MD; Max L. Goodman, MD

AMA Arch Surg. 1968;96(3):410-413.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE incidence of breast sarcoma in contrast to all breast malignancies is 0.3% to 2.7%,^1-8 and the majority of these tumors are fibrosarcomas, with only 62 patients described as having primary lymphoma of the breast.^9-38 Documented reports present controversy as to the relationship of systemic lymphoma to the proper treatment of the lesion.^6,9,14,32 Recently, it was our experience to see a patient with lymphosarcoma of the breast, seven months postpartum followed by systemic lymphoma and death five months after diagnosis. Of the reported patients, 28 have died with systemic malignant lymphoma and others have not been followed for a sufficient period to exclude systemic lymphoma. DeCosse et al's³² nine patients with five-year survivals following diagnosis and treatment are complicated by sequent lymphoma manifestations in three instances. Oberman³⁸ described a patient with five-year survival that had recurrent lymphoma four years after treatment and she has been . . . [Full Text PDF of this Article]

Author Affiliations
Boston

From Boston University School of Medicine, Boston University Medical Center, Boston. Dr. Hofman is a teaching fellow in pathology.

Footnotes
Submitted for publication July 6, 1967.

Reprint requests to 750 Harrison Ave, Boston 02118 (Dr. Goodman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?